Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)
CUSIP: 50127T109
Q4 2016 13F Holders as of 31 Dec 2016
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 88,321,513
- Total 13F shares
- 9,877,148
- Share change
- +128,295
- Total reported value
- $58,241,000
- Price per share
- $5.90
- Number of holders
- 29
- Value change
- +$736,496
- Number of buys
- 11
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 50127T109:
Top shareholders of KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.2%
|
2,815,919
|
$17,599,000 | — | 30 Sep 2016 | |
| EcoR1 Capital, LLC |
13F
|
Company |
3%
|
2,611,906
|
$16,324,000 | — | 30 Sep 2016 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.3%
|
2,007,642
|
$12,548,000 | — | 30 Sep 2016 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.76%
|
670,859
|
$4,193,000 | — | 30 Sep 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.6%
|
533,251
|
$3,333,000 | — | 30 Sep 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.42%
|
372,916
|
$2,330,000 | — | 30 Sep 2016 | |
| Minerva Advisors LLC |
13F
|
Company |
0.36%
|
322,221
|
$2,014,000 | — | 30 Sep 2016 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
64,300
|
$402,000 | — | 30 Sep 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
63,000
|
$394,000 | — | 30 Sep 2016 | |
| Birchview Capital, LP |
13F
|
Company |
0.07%
|
59,114
|
$369,000 | — | 30 Sep 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
48,972
|
$306,000 | — | 30 Sep 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.04%
|
35,022
|
$219,000 | — | 30 Sep 2016 | |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
30,500
|
$191,000 | — | 30 Sep 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
24,400
|
$153,000 | — | 30 Sep 2016 | |
| Partner Investment Management, L.P. |
13F
|
Company |
0.03%
|
23,646
|
$148,000 | — | 30 Sep 2016 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
23,500
|
$147,000 | — | 30 Sep 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
10,887
|
$68,000 | — | 30 Sep 2016 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
9,874
|
$62,000 | — | 30 Sep 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,890
|
$43,000 | — | 30 Sep 2016 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
5,650
|
$35,000 | — | 30 Sep 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,631
|
$23,000 | — | 30 Sep 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
2,529
|
$16,000 | — | 30 Sep 2016 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
1,120
|
$7,000 | — | 30 Sep 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
904
|
$6,000 | — | 30 Sep 2016 | |
| REILLY FINANCIAL ADVISORS, LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2016 |
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2016
As of 31 Dec 2016,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,877,148 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Clough Capital Partners L P, Boxer Capital, LLC, VANGUARD GROUP INC, Minerva Advisors LLC, MORGAN STANLEY, Alethea Capital Management, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2016 vs Q3 2016 Across Filers
Q3 2016 holders
25
Q4 2016 holders
29
Holder diff
4
| Investor | Q3 2016 Shares | Q4 2016 Shares | Share Diff | Share Chg % | Q3 2016 Value $ | Q4 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.